Yes, but bought some longer term puts instead.
The biggest challenge, when viewed from a portfolio perspective — imagine a portfolio of 20 RGC-like setups — is the high borrow fee. The clock is...
It must be incredibly tempting for management to execute a significant secondary offering and secure generational wealth for themselves and their...
It definitely is — but incredibly difficult to catch. A $5 billion increase in market cap would mean a 42% loss. I was prepared for that and I...
It would be a USD 50 billion company at that point. I would be calm with an unrealized loss of 500% in that scenario on a modest-sized position....
It started back in the first part of March.
Here is a comparison with the GME debacle, generated by ChatGPT: The RGC (Regencell Bioscience) story can be seen as more insane than the...
3 weeks ago it traded at USD 78 with a market cap exceeding EBAY. Hardly a small cap. I would have loved to short at that level if there had been...
I have put zdreg on ignore. I don't want to waste more time on him and feel sorry for him. He must have gone through some tough times.
Ah so now you accept that I did in fact short RGC, so you now owe me USD 1 million, correct?
There is quite a difference between a USD 70 million stock and a USD 38 billion (where it traded not so long ago) stock with 12 employees, no...
I see no upside catalysts forever. However, with this crazy stock I guess anything can happen short term. But longer term the market cap makes...
What you’re asking is whether this company is worth USD 10 billion. How could it possibly be worth USD 10 billion? I suppose anything is...
To me, the December 19 $12.50 puts bidding at $4.20 offer the best risk/reward profile at the moment. Your thoughts?
It’s down 21%. I have no confidence in my ability to time anything. I’m simply questioning how some herbal roots, no revenue, and 12 employees...
Separate names with a comma.